LYSO 6, sublingual tablet 30 tablets
Active ingredients: Pyridoxine hydrochloride, Lysozyme hydrochloride
Commercialized according to BDPM
Tablet30 tabletsvoie buccale autre
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LYSO 6, comprimé sublingual
- Pharmaceutical form
- comprimé
- Route of administration
- voie buccale autre
- Presentation description
- 3 plaquette(s) PVC aluminium de 10 comprimé(s)
- Marketing authorisation holder
- PIERRE FABRE MEDICAMENT
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Jan 1967
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62305457CIP73281169CIP133400932811694Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LYSOZYME (CHLORHYDRATE DE)comprimé | 20,00 mg · un comprimé | SA |
| CHLORHYDRATE DE PYRIDOXINEcomprimé | 10,00 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.